Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.24B |
| 2 |
Microsoft
MSFT
|
+$433M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$419M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$332M |
| 5 |
RTX Corp
RTX
|
+$322M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AABA
Altaba Inc
AABA
|
+$267M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$181M |
| 3 |
BCR
CR Bard Inc.
BCR
|
+$134M |
| 4 |
IQVIA
IQV
|
+$134M |
| 5 |
LVLT
Level 3 Communications Inc
LVLT
|
+$121M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.07% |
| 2 | Financials | 5.97% |
| 3 | Healthcare | 5.8% |
| 4 | Consumer Discretionary | 5.2% |
| 5 | Communication Services | 4.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4351
iShares MSCI Turkey ETF
TUR
$213M
| $274K | ﹤0.01% |
6,311
+5,180
| +458% | +$211K |
|
4352
Karyopharm Therapeutics
KPTI
$48M
| $273K | ﹤0.01% |
1,902
+1,425
| +299% | +$229K |
|
4353
Fossil Group
FOSL
$318M
| $272K | ﹤0.01% |
34,880
-176,734
| -84% | -$1.37M |
|
4354
Radware
RDWR
$1.19B
| $272K | ﹤0.01% |
14,030
+1,076
| +8% | +$20.4K |
|
|
SA
4355
CALL
Seabridge Gold
SA
$3.35B
| $272K | ﹤0.01% |
24,100
+15,600
| +184% | +$185K |
|
4356
WesBanco
WSBC
$4B
| $272K | ﹤0.01% |
6,679
+4,155
| +165% | +$170K |
|
4357
Viper Energy
VNOM
$14.7B
| $271K | ﹤0.01% |
11,635
-111,687
| -91% | -$2.26M |
|
|
NUAN
4358
CALL
DELISTED
Nuance Communications, Inc.
NUAN
| $271K | ﹤0.01% |
19,173
-5,891
| -24% | -$79.3K |
|
|
CAA
4359
PUT
DELISTED
CalAtlantic Group, Inc.
CAA
| $271K | ﹤0.01% |
4,800
+3,500
| +269% | +$171K |
|
|
GREK
4360
Global X MSCI Greece ETF
GREK
$316M
| $270K | ﹤0.01% |
8,750
+3,861
| +79% | +$108K |
|
4361
Pacific Biosciences
PACB
$370M
| $270K | ﹤0.01% |
102,238
+99,837
| +4,158% | +$350K |
|
|
IBTX
4362
DELISTED
Independent Bank Group, Inc.
IBTX
| $270K | ﹤0.01% |
3,996
+1,376
| +53% | +$89K |
|
4363
PUT
Albemarle
ALB
$15.5B
| $269K | ﹤0.01% |
2,100
+300
| +17% | +$40.7K |
|
4364
PUT
iShares Core S&P 500 ETF
IVV
$902B
| $269K | ﹤0.01% |
1,000
-800
| -44% | -$210K |
|
4365
Akebia Therapeutics
AKBA
$252M
| $268K | ﹤0.01% |
17,984
+16,416
| +1,047% | +$272K |
|
4366
CALL
Copart
CPRT
$27.5B
| $268K | ﹤0.01% |
24,800
-23,200
| -48% | -$226K |
|
4367
Patrick Industries
PATK
$2.95B
| $268K | ﹤0.01% |
5,778
+4,117
| +248% | +$169K |
|
4368
Preferred Bank
PFBC
$1.25B
| $268K | ﹤0.01% |
4,542
+3,934
| +647% | +$239K |
|
4369
Vericel Corp
VCEL
$2.31B
| $268K | ﹤0.01% |
49,091
+44,262
| +917% | +$204K |
|
|
APRN
4370
PUT
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
| $268K | ﹤0.01% |
369
-475
| -56% | -$356K |
|
|
APU
4371
CALL
DELISTED
AmeriGas Partners, L.P.
APU
| $268K | ﹤0.01% |
+5,800
| New | +$261K |
|
|
ALOG
4372
DELISTED
Analogic Corp
ALOG
| $268K | ﹤0.01% |
3,191
+2,000
| +168% | +$165K |
|
4373
QuidelOrtho
QDEL
$838M
| $267K | ﹤0.01% |
6,172
+125
| +2% | +$5.11K |
|
4374
CALL
Everest Group
EG
$14.4B
| $266K | ﹤0.01% |
1,200
-13,900
| -92% | -$3.13M |
|
4375
PUT
Apogee Enterprises
APOG
$908M
| $265K | ﹤0.01% |
5,800
+4,700
| +427% | +$224K |
|
Similar funds
Barclays's Q4 2017 Portfolio in Review
As of Q4 2017, Barclays held 7,416 positions worth $122B, up 26% from $97.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays deployed $19.9B of net new capital in Q4 2017, opening 435 new positions and adding to 3,853 existing holdings. Its largest new stake was iShares US Home Construction ETF: 198,606 shares worth $8.68M.
By sector, the portfolio is most concentrated in Technology at 7.1% of assets, up from 6.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Altaba Inc, an estimated $267M trimmed.
- Barclays's largest Q4 2017 buy was iShares US Home Construction ETF: 198,606 shares worth $8.68M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.24B increase.
- Barclays's biggest Q4 2017 reduction was Altaba Inc, cutting an estimated $267M.
- Barclays fully exited CR Bard Inc. in Q4 2017, selling an estimated $134M.
- Barclays's ten largest holdings make up 24% of its $122B portfolio in Q4 2017.
- Barclays opened 435 new positions and closed 356 in Q4 2017.
- Barclays's portfolio value rose 26% quarter-over-quarter to $122B.
Based on Barclays's 13F filing for Q4 2017, filed 14 Feb 2018.